نتایج جستجو برای: low molecular weight heparin

تعداد نتایج: 2019271  

Journal: :Clinical and Applied Thrombosis/Hemostasis 2002

Journal: :Pathophysiology of Haemostasis and Thrombosis 1994

Journal: :Journal of Veterinary Internal Medicine 2010

Journal: :Chest 2005
Theodore G Liou Frederick R Adler Barbara C Cahill

1 Amirkhosravi A, Mousa SA, Amaya M, et al. Antimetastatic effect of tinzaparin, a low-molecular-weight heparin. J Thromb Haemost 2003; 1:1972–1976 2 Mousa SA, Mohamed S. Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy. Oncol Rep 2004; 12:683–688 3 Von Tempelhoff GF, Harenberg J, Nieman F, et al. Effect of low-molecular weight heparin...

Journal: :Journal of burn care & research : official publication of the American Burn Association 2011
Jonathan B Lundy Kimberly Lairet Kevin K Chung Evan M Renz

Journal: :The American journal of medicine 2011
Russell D Hull Jane Liang Grace Townshend

OBJECTIVE Post-thrombotic syndrome causes considerable morbidity. The Home-LITE study showed a lower incidence of post-thrombotic syndrome and venous ulcers after 3 months of treating deep vein thrombosis with the low-molecular-weight heparin tinzaparin versus oral anticoagulation. This systematic review examined whether long-term treatment of deep vein thrombosis using low-molecular-weight hep...

Journal: :Archives of internal medicine 2000
R D Hull G E Raskob R F Brant G F Pineo G Elliott P D Stein A Gottschalk K A Valentine A F Mah

BACKGROUND Pulmonary embolism (PE) occurs in 50% or more of patients with proximal deep-vein thrombosis. Low-molecular-weight heparin treatment is effective and safe in patients with deep vein thrombosis and may also be so in patients with PE. Recent rigorous clinical trials have established objective criteria for determining a high probability of PE by perfusion lung scanning. OBJECTIVE To c...

Journal: :American family physician 1999
B F Yeager S C Matheny

Patients with a diagnosis of acute deep venous thrombosis have traditionally been hospitalized and treated with unfractionated heparin followed by oral anticoagulation therapy. Several clinical trials have shown that low-molecular-weight heparin is at least as safe and effective as unfractionated heparin in the treatment of uncomplicated deep venous thrombosis. The use of low-molecular-weight h...

Journal: :Archives of internal medicine 1997
R D Hull G E Raskob G F Pineo W Feldstein D Rosenbloom A Gafni D Green J Feinglass A A Trowbridge C G Elliott

BACKGROUND Postoperative venous thrombosis and pulmonary embolism present a major clinical threat to patients undergoing total hip or knee arthroplasty. We performed an economic evaluation of warfarin sodium and subcutaneous low-molecular-weight heparin sodium prophylaxis comparing cost and effectiveness. METHODS A consecutive series of 1436 patients who underwent hip or knee arthroplasty com...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید